Anti-retroviral drugs: current state and development in the next decade

The pace of discovery of new antiretroviral (ARV) drugs has slowed, although the efficacy and safety of once-daily fixed dose combinations have been extensively investigated. Several traditional ARV drugs remain in phase III clinical trials. This review summarizes current information on ARV drugs in...

Full description

Bibliographic Details
Main Author: Xingquan Zhang
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:Acta Pharmaceutica Sinica B
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383518300789